TrialRMD open2023

The MIDORA trial: a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep in patients with rheumatoid arthritis.

Alan Kivitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.